Choose the correct FDA annual report and reporting period

Which FDA annual report should you prepare?

Start with the application and obligation: IND progress reporting under §312.33, NDA/ANDA annual reporting under §314.81(b)(2), or applicable BLA change and study-status reporting under §§601.12 and 601.70. Retrieve the actual effective or approval date and preceding interval. Match the content and clock to that obligation before assigning the annual-report heading.

Before you begin

FDA Module 1.13 organization across development and postapproval reporting; headings do not create universal obligations.

What you will prepare: A pathway-specific reporting plan with the correct clock, evidence owners and content map.

Identify which clock and obligation you are satisfying

For an IND, begin with when the IND went into effect and the 312.33 annual progress-report obligation. For an approved NDA/ANDA, begin with the U.S. approval anniversary and 314.81(b)(2). For a BLA, identify the relevant 601.12 change-reporting and 601.70 postmarketing-study obligations instead of applying the entire NDA annual-report list by analogy.

The cited regulations use 60-day anniversary-based submission periods in their respective contexts, but their underlying dates and content are not interchangeable. Retrieve the actual agency record and any authorized alternative date. The date of first patient enrollment is not automatically the IND effective date, and a global safety data-lock point is not automatically the U.S. application anniversary.

Turn the heading family into a content map

The catalog contains scientific summaries, labeling and quality changes, individual study information, a forward-looking investigational plan, foreign marketing, distribution, postmarketing-study status, open regulatory business and a DSUR location. Determine which tasks apply to the report you are preparing.

A useful collection sheet contains heading, applicable rule, reporting interval, source system, owner, data status and output location. A heading can be not applicable with a reason, while a relevant item can be incomplete because its data are missing. Do not use blank cells to conceal that distinction. Required information such as an IND brochure revision still needs treatment even if it does not have a uniquely matching 1.13 child heading.

Keep urgent and change-control actions outside the annual waiting room

An annual report is a periodic account, not permission to defer expedited safety reports, field alerts, protocol changes or changes requiring a supplement. Maintain links to those earlier actions and summarize the relevant interval information without pretending the annual report retroactively authorized them.

Fictional editorial exercise: a spreadsheet applies the first global clinical-authorization anniversary to both an IND and an approved NDA. Retrieve each application clock, reconcile prior periods and identify gaps or overlaps. If the actual anniversary is missing, keep the due date unresolved and escalate; do not use the date most convenient for the publishing calendar.

Build the reporting plan from the obligation, not the file name

Use one row per application and reporting obligation. The following comparison identifies the source of the clock; it does not calculate a due date for an application whose records have not been inspected.

Keep the annual interval end separate from the submission deadline. The period covered by the report does not ordinarily stretch to include the entire preparation window merely because the report is due afterward. Record the previous report’s end date, the current interval, each source cutoff and the evidence for the anniversary. Investigate gaps or overlap before requesting departmental sign-off.

Two-application exercise: a development team maintains an IND while a separate application for the same product is approved. The IND and marketing application have different anniversaries. Create separate obligation rows even if the same safety group supplies information to both. Shared data can reduce collection work, but it does not establish a common due date or identical content.

Give each content item one of three explicit dispositions: applicable and complete, applicable but incomplete, or not applicable with a reason. An empty distribution cell does not establish zero distribution; an unreturned safety questionnaire does not establish no new safety information. Name the owner and source that support a negative statement.

If using a global DSUR, reconcile its period and U.S. coverage before treating the IND obligation as satisfied. Use the IND preparation guide, NDA/ANDA guide and study-status guide for the detailed content tasks.

Frequently asked questions

Sources and revisions

Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.

Related guides